CellTrans wins FDA approval for first cell therapy that treats Type 1 diabetes
21/09/2023
No Comments
The FDA has approved the Lantidra allogeneic pancreatic islet cellular therapy developed by CellTrans to treat diabetes. This is the first approval of a donor
